Harnessing the immune response against common moles to combat melanoma
Source: Fierce Biotech, June 2021
About a third of melanomas begin with benign moles. Now, researchers at Massachusetts General Hospital have found an immune mechanism for these noncancerous skin cells that they believe could be leveraged to treat melanoma or prevent its recurrence.
